Brain scan study seeks suicide risk biomarker

NCT ID NCT02811198

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked for biological markers of suicide risk in 97 adults with major depressive disorder. Researchers used brain scans to measure how participants respond to pain, reward, and attention. The goal was to find stable brain-based signs that could help identify those at higher risk for suicide.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a brain-based test to help identify people with depression who are at higher risk for suicide.

What could go wrong

This is an early observational study with only 97 participants. The findings may not apply to everyone and need much more testing before any practical use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

major depressive disorder Suicidal Ideation Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sakina Rizvi

    Toronto, Ontario, M5B1M8, Canada